Related Experiment Video
Updated: Jul 9, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
ITIH4 is a predictor for coronary thrombus in coronary arteriography patients
Lei Tian1, Su Zhao2, Ruiyan Zhang1
1Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Insights
Inter-alpha-trypsin inhibitor heavy chain-4 (ITIH4) may aid in diagnosing coronary artery disease (CAD). Lower ITIH4 levels in CAD patients suggest its potential as a diagnostic biomarker for CAD and predicting coronary thrombus.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Biomarker Discovery
Background:
- Coronary artery disease (CAD) diagnosis relies on invasive procedures like coronary arteriography.
- Novel, non-invasive biomarkers are needed to improve CAD detection and risk stratification.
- Inter-alpha-trypsin inhibitor heavy chain-4 (ITIH4) is a protein with potential, but its role in CAD is not well-established.
Purpose of the Study:
- To investigate the diagnostic value of plasma ITIH4 levels in patients with coronary artery disease (CAD).
- To assess the correlation of ITIH4 with established CAD markers and clinical indicators.
- To determine if ITIH4 can predict the presence of visible thrombus in coronary arteries.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was employed to quantify plasma ITIH4 levels.
- Patients undergoing coronary arteriography (CAG) were recruited for the study.
- Logistic regression analysis was used to evaluate the predictive value of ITIH4.
Main Results:
- Plasma ITIH4 levels were significantly lower in CAD patients compared to the control group.
- ITIH4 levels showed a negative correlation with C-reactive protein (CRP).
- ITIH4 expression correlated significantly with D-Dimer and thrombin time, and predicted visible coronary thrombus.
Conclusions:
- ITIH4 demonstrates potential as a novel biomarker for the diagnosis of coronary artery disease (CAD).
- ITIH4 may serve as a valuable predictor for the presence of visible thrombus in coronary arteries.
- Further research is warranted to validate ITIH4's clinical utility in CAD management.
Abstract:
Aim: To explore potential value of inter-alpha-trypsin inhibitor heavy chain-4 (ITIH4) for coronary artery disease (CAD) diagnosis.Patients & methods: We recruited the patients who received coronary arteriography (CAG) examination. The enzyme-linked immunosorbent assay was used to detect plasma ITIH4.Results: ITIH4 level was lower expression in CAD patients than that in patients of control group, and was negatively correlated with C-reactive protein (CRP). ITIH4 level is no differences between ST-elevated myocardial infarction (STEMI) and non-ST-elevated myocardial infarction (NSTEMI) patients. However, its expression was significantly correlated with D-Dimer and thrombin time, and the logistic analysis confirmed predictive value of ITIH4 for visible thrombus in coronary.Conclusion: ITIH4 may be a useful biomarker in CAD diagnosis, and to predict visible thrombus in coronary.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care

